Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats.
CONCLUSION: Liposomal nanoparticles may improve the solubility and bioavailability of quercetin in liver. Furthermore, nanoliposomal quercetin could effectively protect rats against acute liver injury and may be a new hepatoprotective and therapeutic agent for patients with liver diseases.
PMID: 32059743 [PubMed - in process]
Source: BMC Pharmacology and Toxicology - Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research
More News: Bilirubin | Drugs & Pharmacology | Flavonoids | High Fat | Liver | Liver Disease | Nanotechnology | Study | Toxicology | Urology & Nephrology